EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED - Company Information

Print Friendly Version

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Company Registration Number:
03740936 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2022

Period of accounts

Start date: 01 January 2022

End date: 31 December 2022

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Notes

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Balance sheet

As at 31 December 2022


Notes
2022
2021


£
£
Current assets
Debtors:   304,491 292,172
Total current assets: 304,491 292,172
Creditors: amounts falling due within one year:   (54,360) (61,547)
Net current assets (liabilities): 250,131 230,625
Total assets less current liabilities: 250,131 230,625
Total net assets (liabilities): 250,131 230,625
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 250,130 230,624
Shareholders funds: 250,131 230,625

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 20 June 2023
and signed on behalf of the board by:

Name: Vincent Jongkind
Status: Director

The notes form part of these financial statements

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Income is recognised as turnover when it is receivable under the terms of an associated contract except for income associated with multi-year contracts which is recognised over the term of the contract.

Other accounting policies

Gift Aid Payments - The company pays all of its taxable profits for each reporting period to its parent charity under the gift aid scheme. These gift aid payments are recognised as distributions to owners in equity within retained earnings. At the reporting date there was no legal obligation in place for the company to make this gift aid payment, although prior to the reporting date the board had indicated its intention to pay the taxable profits to the parent charity in respect of the reporting period. The payment is expected to be made within 9 months of the end of the reporting period.

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

2. Employees

2022 2021
Average number of employees during the period 19 16

EUROPEAN VASCULAR SURGERY JOURNALS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Related party transactions

The company's ultimate and immediate parent is European Society for Vascular Surgery, a charitable company registered in England and Wales with registered office at 18 Saxon Way, Romsey, Hampshire, SO51 5PT. Its principal place of business is 275 Boulevard Albert 1er, 33130, Begles, France.